IL200296A0 - Agents for the treatment of multiple sclerosis and methods of using same - Google Patents

Agents for the treatment of multiple sclerosis and methods of using same

Info

Publication number
IL200296A0
IL200296A0 IL200296A IL20029609A IL200296A0 IL 200296 A0 IL200296 A0 IL 200296A0 IL 200296 A IL200296 A IL 200296A IL 20029609 A IL20029609 A IL 20029609A IL 200296 A0 IL200296 A0 IL 200296A0
Authority
IL
Israel
Prior art keywords
agents
treatment
methods
same
multiple sclerosis
Prior art date
Application number
IL200296A
Original Assignee
Rappaport Family Inst For Res
Nathan Karin
Gizi Wildbaum
Yaniv Zohar
Moran Meiron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2008/000166 external-priority patent/WO2008096359A2/en
Application filed by Rappaport Family Inst For Res, Nathan Karin, Gizi Wildbaum, Yaniv Zohar, Moran Meiron filed Critical Rappaport Family Inst For Res
Priority to IL200296A priority Critical patent/IL200296A0/en
Publication of IL200296A0 publication Critical patent/IL200296A0/en

Links

IL200296A 2007-02-08 2009-08-09 Agents for the treatment of multiple sclerosis and methods of using same IL200296A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL200296A IL200296A0 (en) 2007-02-08 2009-08-09 Agents for the treatment of multiple sclerosis and methods of using same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90009407P 2007-02-08 2007-02-08
US92959107P 2007-07-05 2007-07-05
PCT/IL2008/000166 WO2008096359A2 (en) 2007-02-08 2008-02-06 Agents for the treatment of multiple sclerosis and methods of using same
IL200296A IL200296A0 (en) 2007-02-08 2009-08-09 Agents for the treatment of multiple sclerosis and methods of using same

Publications (1)

Publication Number Publication Date
IL200296A0 true IL200296A0 (en) 2010-04-29

Family

ID=42263860

Family Applications (1)

Application Number Title Priority Date Filing Date
IL200296A IL200296A0 (en) 2007-02-08 2009-08-09 Agents for the treatment of multiple sclerosis and methods of using same

Country Status (1)

Country Link
IL (1) IL200296A0 (en)

Similar Documents

Publication Publication Date Title
PL2205273T3 (en) Use of modified cells for the treatment of multiple sclerosis
HK1134679A1 (en) Compositions and methods for the treatment of infections
EP2361089A4 (en) Compositions and methods for the treatment of altered -synuclein function
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
EP2317931A4 (en) Tissue modification devices and methods of using the same
ZA200704677B (en) Compositions and methods for the treatment of autism
EP2023718A4 (en) Creatine-ligand compounds and methods of use thereof
ZA200900388B (en) Compositions and methods for the treatment of mucositis
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
EP2117607A4 (en) Imaging agents and methods of use thereof
GB0604471D0 (en) Device and method for the treatment of tumours
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EP2236150A4 (en) Method for increasing the therapeutic efficacy of curcuminoids and analogues
IL197804A0 (en) Compositions for the trearment of hepatitis c and methods for using compositions for the treatment of hepatitis c
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
GB0718446D0 (en) Compositions and methods for the treatment of infection
IL198723A0 (en) Methods and compositions for therapeutic treatment
IL187405A0 (en) Methods and compositions for the treatment of pain
EP2124968A4 (en) Compositions and methods for the treatment of muscle wasting
EP2007790A4 (en) Compounds and methods for the treatment of pain
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
EP2077117A4 (en) Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases
IL226363A0 (en) Compounds and methods for the treatment of cancer